NCT06485232 - Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Neuromyelitis Optica Spectrum DisordersMyasthenia Gravis, GeneralizedMultiple SclerosisChronic Inflammatory Demyelinating Polyradiculoneuropathy

Interventions

DRUG

Universal BCMA CAR-T

DRUG

Universal CD19 CAR-T

DRUG

Universal BCMA CAR-T; Universal CD19 CAR-T

Trial Locations (1)

Xuanwu Hospital, Capital Medical University, Beijing